Saife Vetmed Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-12-2024
- Paid Up Capital ₹ 1.04 M
as on 06-12-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.96 Cr
as on 06-12-2024
- Satisfied Charges ₹ 1.71 Cr
as on 06-12-2024
- Revenue 37.73%
(FY 2022)
- Profit 122.81%
(FY 2022)
- Ebitda 90.82%
(FY 2022)
- Net Worth 38.55%
(FY 2022)
- Total Assets 17.90%
(FY 2022)
About Saife Vetmed
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.04 M.
The company currently has active open charges totaling ₹3.96 Cr. The company has closed loans amounting to ₹1.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ali Asgar and Tasneem Asgar serve as directors at the Company.
- CIN/LLPIN
U33125DL2006PTC153348
- Company No.
153348
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Saife Vetmed?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ali Asgar  | Director | 01-Apr-2009 | Current |
| Tasneem Asgar | Director | 08-Sep-2006 | Current |
Financial Performance of Saife Vetmed.
Saife Vetmed Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 37.73% increase. The company also saw a substantial improvement in profitability, with a 122.81% increase in profit. The company's net worth Soared by an impressive increase of 38.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saife Vetmed?
In 2022, Saife Vetmed had a promoter holding of 88.00% and a public holding of 12.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saife Overseas Private LimitedActive 15 years 10 monthsAli Asgar and Tasneem Asgar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jan 2024 | ₹2.01 M | Open |
Others Creation Date: 16 Aug 2023 | ₹3.76 Cr | Open |
Others Creation Date: 14 Aug 2013 | ₹1.21 Cr | Satisfied |
How Many Employees Work at Saife Vetmed?
Saife Vetmed has a workforce of 72 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saife Vetmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saife Vetmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
